Published in Biochim Biophys Acta on May 22, 1996
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine (2006) 4.08
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clin Cancer Res (2005) 1.01
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother Pharmacol (2012) 1.01
Functional lipids and lipoplexes for improved gene delivery. Biochimie (2011) 0.96
Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent. Nanoscale Res Lett (2009) 0.89
Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano (2013) 0.88
Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system. Antimicrob Agents Chemother (1998) 0.86
Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int (2013) 0.85
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev (2016) 0.84
Bioavailability of polyphenol liposomes: a challenge ahead. Pharmaceutics (2013) 0.78
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery. Mol Pharm (2015) 0.75
Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA-In). Front Med (Lausanne) (2015) 0.75
Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta (1986) 7.07
Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta (1979) 5.39
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta (1985) 4.47
Osmotic properties of large unilamellar vesicles prepared by extrusion. Biophys J (1993) 3.11
X-ray diffraction study of the polymorphic behavior of N-methylated dioleoylphosphatidylethanolamine. Biochemistry (1988) 2.75
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther (2001) 2.35
Smoothed orientational order profile of lipid bilayers by 2H-nuclear magnetic resonance. Biophys J (1989) 2.33
Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc Natl Acad Sci U S A (1988) 2.22
Lipid polymorphism: the molecular basis of nonbilayer phases. Annu Rev Biophys Biophys Chem (1985) 2.14
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta (1985) 2.05
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim Biophys Acta (2001) 1.78
Effects of fusogenic agent on membrane structure of erythrocyte ghosts and the mechanism of membrane fusion. Nature (1978) 1.74
The polymorphic phase behaviour of phosphatidylethanolamines of natural and synthetic origin. A 31P NMR study. Biochim Biophys Acta (1978) 1.73
Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett (1987) 1.71
Acyl chain orientational order in the hexagonal HII phase of phospholipid-water dispersions. Biophys J (1988) 1.68
Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys J (2001) 1.64
Influence of transbilayer area asymmetry on the morphology of large unilamellar vesicles. Biophys J (1995) 1.64
Lipid polymorphism and the roles of lipids in membranes. Chem Phys Lipids (1986) 1.64
Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem (1992) 1.63
Modulation of the orientational order profile of the lipid acyl chain in the L alpha phase. Eur Biophys J (1990) 1.60
Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta (1991) 1.55
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta (1986) 1.52
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim Biophys Acta (1985) 1.49
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res (1989) 1.47
Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes. Biochim Biophys Acta (1980) 1.47
Phospholipid asymmetry in large unilamellar vesicles induced by transmembrane pH gradients. Biochemistry (1989) 1.39
The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol (1991) 1.34
Stabilized plasmid-lipid particles: construction and characterization. Gene Ther (1999) 1.33
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids (1990) 1.31
Frequency dependence of 31P NMR linewidths in sonicated phospholipid vesicles: effects of chemical shift anisotropy. FEBS Lett (1974) 1.27
Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. Biochemistry (1994) 1.26
Developments in liposomal drug delivery systems. Expert Opin Biol Ther (2001) 1.25
Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J (1997) 1.25
Influence of cholesterol on the structural preferences of dioleoylphosphatidylethanolamine-dioleoylphosphatidylcholine systems: a phosphorus-31 and deuterium nuclear magnetic resonance study. Biochemistry (1982) 1.25
Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm (1989) 1.24
Comparison of the orientational order of lipid chains in the L alpha and HII phases. Biochemistry (1990) 1.23
Factors affecting the motion of the polar headgroup in phospholipid bilayers. A 31P NMR study of unsonicated phosphatidylcholine liposomes. Biochim Biophys Acta (1976) 1.22
Polymorphic phase behaviour of lipid mixtures as detected by 31P NMR. Evidence that cholesterol may destabilize bilayer structure in membrane systems containing phosphatidylethanolamine. Biochim Biophys Acta (1978) 1.22
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta (1990) 1.21
Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry (1996) 1.20
Application of 31P NMR to model and biological membrane systems. FEBS Lett (1975) 1.19
Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev (2001) 1.19
Techniques for encapsulating bioactive agents into liposomes. Chem Phys Lipids (1986) 1.18
Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta (1985) 1.18
On the mechanism of transbilayer transport of phosphatidylglycerol in response to transmembrane pH gradients. Biochemistry (1990) 1.18
Transbilayer transport of phosphatidic acid in response to transmembrane pH gradients. Biochemistry (1991) 1.17
Lateral diffusion rates of phosphatidylcholine in vesicle membranes: effects of cholesterol and hydrocarbon phase transitions. FEBS Lett (1976) 1.16
Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem (1986) 1.14
Fusion of phospholipid vesicles in association with the appearance of lipidic particles as visualized by freeze fracturing. Biochim Biophys Acta (1979) 1.14
Liposomal doxorubicin. J Drug Target (1996) 1.13
Effects of tumbling and lateral diffusion on phosphatidylcholine model membrane 31P-NMR lineshapes. Biochim Biophys Acta (1980) 1.12
Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. Biochim Biophys Acta (1998) 1.11
Polymorphism of phosphatidylglycerol-phosphatidylethanolamine model membrane systems: a 31p NMR study. Biochem Biophys Res Commun (1980) 1.11
31P NMR studies of unsonicated aqueous dispersions of neutral and acidic phospholipids. Effects of phase transitions, p2H and divalent cations on the motion in the phosphate region of the polar headgroup. Biochim Biophys Acta (1976) 1.11
Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim Biophys Acta (1998) 1.11
Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys J (2000) 1.11
Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids. Biochemistry (1996) 1.11
Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta (1994) 1.10
Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry (1996) 1.10
Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem (1995) 1.09
Lipid polymorphism and hydrocarbon order. Biochem Cell Biol (1990) 1.09
Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol (1993) 1.08
Influence of local and neutral anaesthetics on the polymorphic phase preferences of egg yolk phosphatidylethanolamine. Biochim Biophys Acta (1981) 1.08
Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J Cell Biol (1993) 1.07
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia. Cancer Chemother Pharmacol (1993) 1.07
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Cancer Res (1994) 1.07
The lipidic particle as an intermediate structure in membrane fusion processes and bilayer to hexagonal HII transitions. Biochim Biophys Acta (1980) 1.07
Application of 31P-NMR saturation transfer techniques to investigate phospholipid motion and organization in model and biological membranes. Biochim Biophys Acta (1980) 1.06
Correlation between lipid plane curvature and lipid chain order. Biophys J (1996) 1.05
Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. Anal Biochem (1990) 1.05
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. Cancer Res (1990) 1.04
Differential scanning calorimetry and 31P NMR studies on sonicated and unsonicated phosphatidylcholine liposomes. Biochim Biophys Acta (1975) 1.04
Effects of cholesterol on the properties of equimolar mixtures of synthetic phosphatidylethanolamine and phosphatidylcholine. A 31P NMR and differential scanning calorimetry study. Biochim Biophys Acta (1978) 1.04
Effects of divalent cations and pH on phosphatidylserine model membranes: a 31P NMR study. Biochem Biophys Res Commun (1980) 1.04
Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim Biophys Acta (2000) 1.03
Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta (1994) 1.03
Lipid asymmetry induced by transmembrane pH gradients in large unilamellar vesicles. J Biol Chem (1987) 1.02
Optimized procedures for the coupling of proteins to liposomes. J Immunol Methods (1990) 1.02
The role of nonbilayer lipid structures in the fusion of human erythrocytes induced by lipid fusogens. Biochim Biophys Acta (1981) 1.01
Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). J Pharmacol Exp Ther (1997) 1.01
Ca2+ and pH induced fusion of small unilamellar vesicles consisting of phosphatidylethanolamine and negatively charged phospholipids: a freeze fracture study. Biochem Biophys Res Commun (1983) 1.00
Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients. Biochim Biophys Acta (1999) 1.00
Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J Drug Target (2000) 1.00
Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor. Cancer Lett (1990) 0.99
Lipid-based systems for the intracellular delivery of genetic drugs. Mol Membr Biol (1999) 0.99
Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther (2000) 0.99
Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim Biophys Acta (1993) 0.98
The polymorphic phase behaviour of mixed phosphatidylserine-phosphatidylethanolamine model systems as detected by 31P-NMR. Biochim Biophys Acta (1981) 0.97
Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol (1995) 0.97
Modulation of membrane structure by Ca2+ and dibucaine as detected by 31P NMR. Biochim Biophys Acta (1979) 0.97
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). Blood (1985) 0.96
Polymorphic phase behaviour of cardiolipin as detected by 31P NMR and freeze-fracture techniques. Effects of calcium, dibucaine and chlorpromazine. Biochim Biophys Acta (1978) 0.96
Phospholipids and membrane transport. Can J Biochem (1980) 0.95
Long-circulating vectors for the systemic delivery of genes. Curr Opin Mol Ther (2001) 0.95
Non-bilayer structures in membrane fusion. Ciba Found Symp (1984) 0.95